Abstract
To validate the correlation between ANXA3 expression and prognosis in breast cancer, a retrospective study encompassing 309 breast cancer patients was performed. The expression of ANXA3 was determined by the immunohistochemical examination of tissue sections by the Max Vision™ method. The ANXA3 levels in the patient samples were validated for the prognosis based on age, menopause status, tumor size, tumor node, metastasis stage, the number of lymphatic metastases, oncology grade, and molecular subtyping. An elevated expression of ANXA3 was detected in breast cancer samples, compared to adjacent tissue samples, and significant correlation depending on the number of lymphatic metastases (P= 0.001) and histological grade (P= 0.004) was observed. The number of lymphatic metastases and ANXA3 expression were identified as independent risk factors affecting the disease-free survival and overall survival. Significantly (P< 0.002) higher level of ANXA3 was detected in triple-negative breast cancer compared to other subtypes. There was no significant (P> 0.05) change in the expression of ANXA3 with respect to age, menopausal status, tumor size, and clinical stage. The findings implicate the expression of ANXA3 with the natural progressio...Continue Reading
References
Jul 1, 1990·The Journal of Cell Biology·D D Schlaepfer, H T Haigler
May 1, 1989·Cancer·H J HelinJ J Isola
Feb 1, 1984·Cancer·J L Wittliff
Jan 1, 1994·Annual Review of Biophysics and Biomolecular Structure·M A Swairjo, B A Seaton
Nov 1, 1993·The Journal of Cell Biology·C SchlüterJ Gerdes
Mar 28, 2002·Physiological Reviews·Volker Gerke, Stephen E Moss
May 23, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Rosa C M Y LiangMaxey C M Chung
Jul 24, 2003·The Surgical Clinics of North America·S Eva SingletaryFrederick L Greene
Nov 20, 2003·Proteomics·Ali R ShekouhEithne Costello
May 31, 2006·Molecular & Cellular Proteomics : MCP·Juan Madoz-GúrpideJ Ignacio Casal
Jan 29, 2008·European Urology·Jens KöllermannAndré Schrattenholz
Aug 14, 2008·The Journal of Pathology·S Mussunoor, G I Murray
Sep 18, 2008·The Journal of Pathology·Y F LiuZ-C Chen
Jan 28, 2010·Cancer Research·Xuedong YanLingya Pan
Feb 20, 2010·The American Journal of Pathology·Cristina BianchiRoberto A Perego
Jul 6, 2010·World Journal of Urology·C ProtzelJ Giebel
Sep 15, 2010·Annals of Surgical Oncology·Chang Ohk SungSeok-Hyung Kim
Feb 25, 2011·PloS One·Michael J BaineSurinder K Batra
Dec 23, 2011·Journal of Cellular Biochemistry·Shi-Wen TongDa-Zhi Zhang
Jan 13, 2012·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Sep 27, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Na WuMing-Zhong Sun
Oct 4, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P Boyle
May 2, 2013·Experimental and Molecular Pathology·Chao ZengJinbao Yin
Oct 9, 2013·Archives of Pathology & Laboratory Medicine·Antonio C WolffUNKNOWN College of American Pathologists
Mar 18, 2015·British Journal of Pharmacology·R J Flower, M Perretti
Jun 21, 2015·Oncotarget·Bashar ZeidanPaul A Townsend
May 18, 2016·Breast Cancer Research and Treatment·Kamaljeet SinghC James Sung
Citations
Sep 18, 2017·Molecular and Cellular Biochemistry·M Aravind KumarM Lakshmi Narasu
Feb 12, 2019·Molecular Reproduction and Development·Na LiLin Hou
Apr 19, 2019·Journal of Cellular Biochemistry·Ruisi XuSiqi Zhang
Apr 12, 2019·Interdisciplinary Sciences, Computational Life Sciences·Anil Kumar TomarBishwajit Kundu
Sep 17, 2019·Molecular Medicine Reports·Xinxin ZengZhaoxu Li
Jan 19, 2021·ACS Biomaterials Science & Engineering·Shahriare HossainMenake E Piyasena
Mar 7, 2021·Journal of Personalized Medicine·Noshad PeyravianEhsan Nazemalhosseini Mojarad
Aug 7, 2021·Frontiers in Molecular Biosciences·Liu YangSong Qu
Oct 30, 2021·Oncology Letters·Chao LiuXue Feng